Michael Garrison will lead the Medical segment for the Franklin Lakes medical tech company, and Richard Byrd will take over the Interventional segment. Both appointments are effective Sept. 6. 

As part of the arrangement, the Franklin Lakes-based medical technology provider will offer Accelerate Diagnostics’ kits for antimicrobial resistance through its global sales network. 

Flow cytometry is an emerging technology that can help medical professionals better understand disease, according to Dr. Bill Hanlon, chief scientific officer at the North Carolina-based life sciences company. 

The deal to buy MedKeeper, a provider of cloud-based management applications, will help the Franklin Lakes firm "optimize the preparation of compounded medications—a critical need in the pharmacy today."

The move, announced in June, expands the company's reach into the $600 million pharmacy automation market segment, which is expected to grow about 10% annually to $1.5 billion in the U.S. alone over 10 years.

Rishi Grover will lead the Franklin Lakes company’s logistics; operations; procurement; sustainability; and environmental, health and safety teams.

The Franklin Lakes company announced its BD MAX Respiratory Viral Panel is now available in countries that recognize the CE mark certification, with plans to submit soon for FDA Emergency Use Authorization in the U.S.

The announcement includes lots of the Franklin Lakes company's intraosseous needle set kits, manual driver kits and powered drivers.

The arrangement will allow the Franklin Lakes medical company access to de-identified information — which means individuals’ identities are protected — to help it more accurately assess patients' needs.

The Franklin Lakes medical company will work with Spain's CerTest Biotec to develop a molecular diagnostic assessment for the virus.

Simon Campion – who has served as executive vice president and president of the Franklin Lakes company's Interventional unit since September 2018 – will succeed Alberto Mas as president.

The purchase of Parata expands the Franklin Lakes medical company's reach into the $600 million pharmacy automation market, which is expected to grow approximately 10% annually to $1.5 billion in the U.S. alone over 10 years.